Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells

Front Cell Dev Biol. 2023 Nov 30:11:1308025. doi: 10.3389/fcell.2023.1308025. eCollection 2023.
No abstract available

Keywords: DOT1l; breast cancer; epigenetics; estrogen receptor alpha; methylation; reduced representation bisulfite sequencing.

Associated data

  • figshare/10.6084/m9.figshare.22140335.v5

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the AIRC Foundation for Cancer Research (Grant No. IG-23068), the Italian Ministry for University and Research (PRIN 2022: 2022Y79PT4 to AW and PRIN 2022: 202282CMEA to GN), the Italian Ministry of Health (Young Researcher Grant GR-2021-12373937 to GN), and the University of Salerno (Fondi FARB 2022 and 2023). IT is a PhD student of the Research Doctorate in “Molecular Oncology, Immunology, and Experimental Development of Innovative Therapies” of the University of Catanzaro “Magna Graecia.” AS is a resident of the Postgraduate School in Clinical Pathology and Clinical Biochemistry of the University of Salerno.